a patient/client with a bilateral profound sensory/neural hearing loss reports little benefit from their new power btes. verification demonstrates significantly limited dynamic ranges; speech mapping meets nal-r prescriptive fitting targets; and aided siis are 2% and 3%. what should be recommended?
